A Curriculum in Development

The curriculum is written for physicians, pharmacists, nurse practitioners, physician assistants, researchers, and students who want a working understanding of peptide science, pharmacology, and the regulatory landscape. Tier 1 is open to anyone. Tiers 2 and 3 include tracks that are more clinically oriented.

No. AAPM is an educational academy, not a licensing or accrediting body. Certificates issued by the program document successful completion of coursework and a demonstrated understanding of the material. They do not convey any authority, license, or clinical privilege, and they do not substitute for medical, pharmacy, or nursing licensure. Prescribing, compounding, and administering peptides are governed by the licensing boards and regulatory agencies in your jurisdiction.

The program is not currently accredited by any external body. AAPM is in active conversation with academic partners about future accreditation pathways. No accreditation claims are being made today.

Not at launch. AAPM is exploring pathways to CE and CME accreditation through academic partners and professional bodies. If and when credit becomes available, it will be announced separately and tied to specific courses. The curriculum is designed so that credit-eligibility can be added later without restructuring the coursework.

Pricing has not been finalized. The current plan is a per-course fee structure, with AAPM members receiving discounted access. Members will be notified of pricing before enrollment opens.

The first course, Peptide Medicine Foundations, is in active content development. No public launch date has been set. The best way to be notified is to become an AAPM member or contact the academy directly about institutional partnerships.